Clinical, Biochemical and Molecular Characteristics of Fifteen Patients with Mucopolysaccharidosis Type II in Western Turkey

Aim:Mucopolysaccharidosis Type II (MPS II, Hunter syndrome, OMIM 309900) is a rare X-linked lysosomal storage disease due to a deficiency of the iduronate-2-sulfatase (IDS) enzyme, which is one of the degradative enzymes of mucopolysaccharides. The purpose of this study is to present the clinical, b...

Full description

Bibliographic Details
Published in:	Journal of Pediatric Research
Main Authors:	Havva Yazıcı, Ebru Canda, Esra Er, Sema Kalkan Uçar, Hüseyin Onay, Ferda Özkınay, Mahmut Çoker
Format:	Article
Language:	English
Published:	Ege University, Faculty of Medicine, Department of Pediatrics and Ege Children Foundation 2018-03-01
Subjects:	Mucopolysaccharidosis Type II Hunter syndrome lysosomal storage disease Turkey
Online Access:	http://jpedres.org/archives/archive-detail/article-preview/clinical-biochemical-and-molecular-characteristics/18767

Similar Items

Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland
by: Zbigniew Żuber, et al.
Published: (2023-06-01)

Clinical Features of 29 Patients with Hereditary Tyrosinemia I in Western Turkey
by: Havva Yazıcı, et al.
Published: (2018-03-01)

Novel Phenotypic Insights into the <i>IDS</i> c.817C>T Variant in Mucopolysaccharidosis Type II from Newborn Screening Cohorts
by: Éliane Beauregard-Lacroix, et al.
Published: (2025-08-01)

A Mortal Complication in a Case with Mucopolysaccharidosis type I Following Hematopoietic Stem Cell Transplantation: Pulmonary Haemorrhage
by: Havva Yazıcı, et al.
Published: (2021-08-01)

Management of Difficult Airway in a Patient with Mucopolysaccharidosis Type II
by: Damla Hanalioğlu, et al.
Published: (2019-08-01)

Mucopolysaccharidosis Type-II with Pathognomonic Skin Appearance: A Case with Pebbling Sign
by: Ayşe Hitay İnan, et al.
Published: (2021-06-01)

Neuroradiological Characteristics in Patients with Mucopolysaccharidosis Type II: A Systematic Review
by: Yancarlos Ramos-Villegas, et al.
Published: (2023-02-01)

Initial and Final Status of the Patients with Niemann Pick A and B: Ege University Experience
by: Ebru Canda, et al.
Published: (2018-03-01)

Identification of 17 novel mutations in 40 Argentinean unrelated families with mucopolysaccharidosis type II (Hunter syndrome)
by: H. Amartino, et al.
Published: (2014-01-01)

Modeling Mucopolysaccharidosis Type II in the Fruit Fly by Using the RNA Interference Approach
by: Laura Rigon, et al.
Published: (2020-10-01)

Clinical Presentation and Follow Up of Patients with Mucopolysaccharidosis Type IVA (Morquio A Disease): Single Center Experience
by: Ebru Canda, et al.
Published: (2018-03-01)

Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain
by: Valeria De Pasquale, et al.
Published: (2020-02-01)

Mucopolysaccharidosis type II (Hunter syndrome) in a boy from the Republic of Serbia: A case report
by: Tubić-Vukajlović Jovana M., et al.
Published: (2023-01-01)

Stomatological Problems in Child with the II Type Mucopolysaccharidosis
by: L. Baborská, et al.
Published: (2013-12-01)

Imaging hallmarks of mucopolysaccharidosis in a young Ethiopian boy: A case report
by: Muluken Yifru Gebresilassie, MD, et al.
Published: (2025-09-01)

Manifestaciones bucales de pacientes con mucopolisacaridosis// Oral manifestations in patients with mucopolysaccharidosis
by: Andrea Veronica Rios
Published: (2021-01-01)

Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II
by: Narutoshi Yamazaki, et al.
Published: (2023-12-01)

Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know
by: Stefania Costi, et al.
Published: (2022-12-01)

Clinical investigator perspectives on patient outcomes in children with neuronopathic mucopolysaccharidosis II during intrathecal idursulfase-IT treatment
by: Karen S. Yee, et al.
Published: (2024-04-01)

Enzyme Replacement Therapy with Idursulfase in Patients with Mucopolysaccharidosis Type II: Literature Review
by: Nato D. Vashakmadze, et al.
Published: (2021-12-01)

Two-year follow-up after drug desensitization in mucopolysaccharidosis
by: Federico Spataro, et al.
Published: (2024-12-01)

Caregiver experiences and observations of intrathecal idursulfase-IT treatment in a phase 2/3 trial in pediatric patients with neuronopathic mucopolysaccharidosis II
by: Karen S. Yee, et al.
Published: (2024-03-01)

Validation and Implementation of a Highly Sensitive and Efficient Newborn Screening Assay for Mucopolysaccharidosis Type II
by: Heather Bilyeu, et al.
Published: (2020-10-01)

Comprehensive Characterization of a Cluster of Mucopolysaccharidosis IIIB in Ecuador
by: María Lucía Castro Moreira, et al.
Published: (2025-09-01)

Clinical, Neuroimaging, and Genetic Features of the Patients with L-2-Hydroxyglutaric Aciduria
by: Ebru Canda, et al.
Published: (2018-03-01)

Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
by: Tapiero-Rodriguez SM, et al.
Published: (2018-04-01)

Unmet needs of adults living with mucopolysaccharidosis II: data from the Hunter Outcome Survey
by: Joseph Muenzer, et al.
Published: (2025-07-01)

Avaliação prospectiva de 11 pacientes brasileiros com mucopolissacaridose II Prospective study of 11 Brazilian patients with mucopolysaccharidosis II
by: Louise L. C. Pinto, et al.
Published: (2006-08-01)

Roentgenographic diagnosis of mucopolysaccharidosis with particular reference to Morquio syndrome
by: umesh chandra parashari, et al.
Published: (2012-02-01)

Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II
by: Zackary M. Herbst, et al.
Published: (2022-01-01)

Persistent moderate methylmalonic aciduria in a patient with methylmalonyl CoA epimerase deficiency
by: Havva Yazıcı, et al.
Published: (2022-10-01)

Recovery of Vision following Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II, Hunter Syndrome
by: Ryutaro Yamanishi, et al.
Published: (2019-06-01)

Clinical Profile Among Brazilian Mucopolysaccharidosis type II Patients: Subgroup Analysis from the Hunter Outcome Survey
by: Dafne D G Horovitz, et al.
Published: (2023-09-01)

Neurocognitive testing in a murine model of mucopolysaccharidosis type IIIA
by: Kleopatra Pericleous, et al.
Published: (2023-09-01)

A Retrospective Study of Mucopolysaccharidosis Type II in Brazil - Data from Brazilian Health System (DATASUS)
by: Fernanda Tenório, et al.
Published: (2023-10-01)

A Systematic Literature Review on the Global Status of Newborn Screening for Mucopolysaccharidosis II
by: Olulade Ayodele, et al.
Published: (2024-10-01)

Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA
by: Sharon J. Chin, et al.
Published: (2020-09-01)

Mucopolysaccharidosis type IVA in children: Clinical cases
by: A. V. Burlutskaya, et al.
Published: (2022-02-01)

Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020-02-01)

Intracerebroventricular Enzyme Replacement Therapy in Patients with Neuropathic Form of Mucopolysaccharidosis Type II: to Help Practicing Physician
by: Nataliya V. Zhurkova, et al.
Published: (2024-09-01)